The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 14, 2024
Filed:
Jul. 08, 2016
Applicant:
American Gene Technologies International, Inc., Rockville, MD (US);
Inventor:
Charles David Pauza, Rockville, MD (US);
Assignee:
American Gene Technologies International Inc., Rockville, MD (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 35/17 (2015.01); A61K 39/12 (2006.01); A61K 39/21 (2006.01); A61P 31/18 (2006.01); C12N 15/113 (2010.01); C12N 15/86 (2006.01); C12Q 1/06 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/21 (2013.01); A61K 35/17 (2013.01); A61K 39/12 (2013.01); A61P 31/18 (2018.01); C12N 15/1138 (2013.01); C12N 15/86 (2013.01); C12Q 1/06 (2013.01); A61K 2039/5156 (2013.01); A61K 2039/5158 (2013.01); A61K 2039/57 (2013.01); A61K 48/00 (2013.01); C12N 2310/14 (2013.01); C12N 2740/15041 (2013.01); C12N 2740/15043 (2013.01); C12N 2740/16034 (2013.01); C12N 2740/16041 (2013.01);
Abstract
The present invention relates generally to immunization and immunotherapy for the treatment or prevention of HIV. In particular, the methods relate to in vivo and ex vivo enrichment of HIV-specific CD4 T cells. In certain embodiments, the disclosed compositions and methods can incorporate therapy in order to further enhance the HIV-specific CD4 T cells.